Opinion
PARP inhibitors: New developments in ovarian cancer treatment
- Author:
- Arthur-Quan Tran, MD
- Emma C. Rossi, MD
Publish date: June 5, 2017
Maturing data from ongoing trials will likely expand the opportunity to use PARP inhibitors for the treatment of ovarian cancer.
Opinion
Optimizing surveillance for gynecologic cancers
- Author:
- Emma C. Rossi, MD
Publish date: May 3, 2017
High-quality surveillance care requires vigilance in the detection of recurrence, but also in the avoidance of unnecessary, costly, and inaccurate...
Article
Ovarian cancer screening update
- Author:
- Stuart R. Pierce, MD
- Emma C. Rossi, MD
Publish date: February 3, 2017
The average lifetime risk of developing ovarian cancer is low, approximately 1 in 70. Even a clinical test with 100% sensitivity and 99%...
News
Sentinel lymph node technique in endometrial cancer, Part 2
- Author:
- Emma C. Rossi, MD
- Stephanie A. Sullivan, MD
Publish date: October 3, 2016
The sentinel lymph node technique strikes a balance between the risks and benefits of lymph node evaluation in endometrial cancer.